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A previously healthy 23-year-old female developed a painfulnecrotizing wound approximately 5 days after a caesarean
section (Fig. 1). Her laboratory results showed a leukocytosis of
43,200/mm³ (reference 4,500–11,000) and a C-reactive protein
(CRP) level of 462 mg/L (reference 0–5 mg/L).
Based on appearance and lack of clinical improvement after
the initiation of broad spectrum antibiotics, a presumptive
diagnosis of pyoderma gangrenosum (PG) was made. Cyclo-
sporine therapy was initiated with prompt improvement of the
wound (Figs. 2 and 3).
PG is an uncommon skin disease that frequently presents as
a painful ulcer. It is more frequent in women and has the highest
incidence between 25 and 55 years of age. Approximately 50% of
cases are associated with systemic diseases such as inflamma-
tory bowel disease (mainly UC), rheumatoid arthritis, systemic
lupus erythematosus and hematological malignancies or solid
tumours of colon, bladder, breast, lung or ovarium 1,2.
Minor trauma or surgery of the skin can initiate the pathologic
process—called the ‘pathergy phenomenon’—although it is less
frequently associated with a caesarean section 3.
Diagnosis depends on clinical presentation, exclusion of
other causes—such as infection, malignancy and vasculitis—
as well as response to treatment. Biopsy in PG is non-specific
but can be helpful to rule out other diseases.
Corticosteroids are first-choice therapy and often lead to a
rapid and persisting healing 1,4–6. In steroid refractory cases,
immunomodulatory therapy such as cyclosporines (typically
5 mg/kg.day) may give long-lasting remission. Intravenous
immunoglobulins, infliximab, mycophenolate mofetil, tacroli-
mus and plasmapheresis have been used.
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Figure 2. Wound seen four days after the initiation of cyclosporine
therapy. There was already an improvement with a diminished
swelling of the surrounding skin and the disappearance of the
erythematous margin.
Figure 1. Wound seen twenty-seven days postoperatively.
Figure 3. Wound seen fifty-five days after the start of cyclosporine
therapy.
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